孤立性创伤性脑损伤的扩展凝血分析:CENTER-TBI 分析
该研究嵌入前瞻性多国CENTER-TBI研究,纳入严格孤立性TBI患者88例,按入院常规INR分为INR<1.2组(n=72)与INR≥1.2组(n=16),检测常规凝血以外的扩展凝血与纤溶指标。INR≥1.2组进行性颅内出血发生率高,并与死亡率升高和不良结局相关;凝血因子V、VIII、IX、XIII活性组间平均下降15–20%,蛋白C和S下降20%,凝血酶生成峰值高度与内源性凝血酶潜能(ETP)降低,纤维蛋白单体增加。纤溶方面,纤溶酶原活性从INR<1.2组的89%显著降至INR≥1.2组的76%,D-二聚体均值从943 mg/L显著升至1,301 mg/L。作者认为这提示孤立性TBI伴止血异常者凝血与纤溶存在反向平衡调节,所观察到的因子水平变化是否与更差结局或更严重脑损伤相关仍属推测。
要点
- 孤立性TBI入院INR≥1.2(n=16)较INR<1.2(n=72)进行性颅内出血发生率高,并与死亡率升高和不良结局相关。
- INR≥1.2组凝血因子V、VIII、IX、XIII活性较INR<1.2组平均下降15–20%,蛋白C和S水平下降20%。
- INR升高时凝血酶生成减少(峰值高度与内源性凝血酶潜能ETP降低),纤维蛋白单体量增加。
- 纤溶酶原活性从INR<1.2组的89%显著降至INR≥1.2组的76%;D-二聚体均值从943 mg/L显著升至1,301 mg/L。
- 作者认为这提示孤立性TBI伴止血异常者凝血与纤溶存在反向平衡调节,因子水平变化与更差结局或更严重脑损伤的关系仍属推测。
适用人群与场景
- 嵌入前瞻性多国CENTER-TBI研究,纳入严格孤立性TBI(iTBI)患者88例,取入院时采集的血样(枸橼酸/EDTA)与CENTER-TBI中央数据库的临床及常规实验室数据匹配。
- 按入院常规INR分层:INR<1.2组72例,INR≥1.2组16例;INR>1.2在普通创伤人群中已被长期采用为创伤相关凝血病的定义阈值。
诊断标准与关键阈值
- 以常规INR分层:INR<1.2与INR≥1.2;原文指出INR>1.2在普通创伤人群中已被长期采用作为创伤相关凝血病的阈值。
红旗征与不能漏的情况
- 孤立性TBI患者入院INR≥1.2时进行性颅内出血发生率高,并与死亡率升高和不良结局相关。
研究设计与关键结果
- 研究类型为嵌入前瞻性多国CENTER-TBI研究的凝血分析,纳入严格孤立性TBI患者88例(INR<1.2组n=72,INR≥1.2组n=16)。
- INR≥1.2组(n=16)较INR<1.2组(n=72)进行性颅内出血发生率高,并与死亡率升高和不良结局相关。
- 凝血因子V、VIII、IX、XIII活性在两组间平均下降15–20%,蛋白C和S水平下降20%。
- INR升高时凝血酶生成减少,表现为峰值高度和ETP降低,纤维蛋白单体量增加。
- 纤溶酶原活性从INR<1.2组的89%显著降至INR≥1.2组的76%;D-二聚体均值从INR<1.2组的943 mg/L显著升至INR≥1.2组的1,301 mg/L。
证据类型、等级与局限
- 证据类型:嵌入前瞻性多国CENTER-TBI研究的凝血分析。
- 局限:作者指出所观察到的因子水平变化是否具有相关性并解释更差结局或更严重脑损伤本身仍属推测。
对床旁实践的改变
- 作者认为,超越常规凝血检测的深入分析提示孤立性TBI伴止血异常者存在凝血与纤溶的反向平衡调节,所观察到的涉及复杂动态凝血系统关键通路的特定模式为进一步研究提供了机会。
- 作者指出,所观察到的因子水平变化是否具有相关性并解释更差结局或更严重脑损伤本身仍属推测。
指南或共识出处
- CENTER-TBI(Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury)研究
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Trauma-induced coagulopathy in traumatic brain injury (TBI) remains associated with high rates of complications, unfavorable outcomes, and mortality. The underlying mechanisms are largely unknown. Embedded in the prospective multinational Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, coagulation profiles beyond standard conventional coagulation assays were assessed in patients with isolated TBI within the very early hours of injury.
METHODS: Results from blood samples (citrate/EDTA) obtained on hospital admission were matched with clinical and routine laboratory data of patients with TBI captured in the CENTER-TBI central database. To minimize confounding factors, patients with strictly isolated TBI (iTBI) (n = 88) were selected and stratified for coagulopathy by routine international normalized ratio (INR): (1) INR < 1.2 and (2) INR ≥ 1.2. An INR > 1.2 has been well adopted over time as a threshold to define trauma-related coagulopathy in general trauma populations. The following parameters were evaluated: quick's value, activated partial thromboplastin time, fibrinogen, thrombin time, antithrombin, coagulation factor activity of factors V, VIII, IX, and XIII, protein C and S, plasminogen, D-dimer, fibrinolysis-regulating parameters (thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor 1, antiplasmin), thrombin generation, and fibrin monomers.
RESULTS: Patients with iTBI with INR ≥ 1.2 (n = 16) had a high incidence of progressive intracranial hemorrhage associated with increased mortality and unfavorable outcome compared with patients with INR < 1.2 (n = 72). Activity of coagulation factors V, VIII, IX, and XIII dropped on average by 15-20% between the groups whereas protein C and S levels dropped by 20%. With an elevated INR, thrombin generation decreased, as reflected by lower peak height and endogenous thrombin potential (ETP), whereas the amount of fibrin monomers increased. Plasminogen activity significantly decreased from 89% in patients with INR < 1.2 to 76% in patients with INR ≥ 1.2. Moreover, D-dimer levels significantly increased from a mean of 943 mg/L in patients with INR < 1.2 to 1,301 mg/L in patients with INR ≥ 1.2.
CONCLUSIONS: This more in-depth analysis beyond routine conventional coagulation assays suggests a counterbalanced regulation of coagulation and fibrinolysis in patients with iTBI with hemostatic abnormalities. We observed distinct patterns involving key pathways of the highly complex and dynamic coagulation system that offer windows of opportunity for further research. Whether the changes observed on factor levels may be relevant and explain the worse outcome or the more severe brain injuries by themselves remains speculative.
参考来源
- Böhm JK, Schaeben V, Schäfer N, et al. Extended Coagulation Profiling in Isolated Traumatic Brain Injury: A CENTER-TBI Analysis. Neurocrit Care. 2021. PMID: 34918214. doi:10.1007/s12028-021-01400-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。